HuagongsheHuagongshe Chemistry Print Report · For research reference only
IRE1|A kinase-IN-9 → 4-(7-Hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)-N-(2-morpholinoethyl)benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | IRE1|A kinase-IN-9 | HCID 54575078 | — |
| Reactant | 6-Hydroxy-2-(4-(4-methylpiperazine-1-carbonyl)phenyl)quinoline-5-carbaldehyde | HCID 54575929 | — |
| Solvent | Methanesulfonic Acid | HCID 6395 | — |
| Product | 4-(7-Hydroxy-4-methyl-2-oxo-2H-chromen-3-yl)-N-(2-morpholinoethyl)benzamide | HCID 86683427 | 18% |
Reaction Steps
Compound 4 (5 g, 21.2 mmol) and compound 5 (5.6 g, 24.3 mmol) were stirred at 0° C. CH3SO3H (50 mL) was added dropwise. Then the mixture was stirred at RT for 16 h. The reaction mixture was poured into crush ice, extracted by DCM. The DCM layer was washed with sat.Na2HPO4, dried over Na2SO4, filtered, concentrated. The residue was purified by silica gel column (DCM:EtOH=50:1), afforded compound 6 (1.2 g, 18%) as light yellow solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09040714B2 |
| Source dataset | uspto-grants-2015_05 |
| ORD ID | ord-06b1eb6e9601490a959bbc76692d636d |
| Source note | uspto-grants-2015_05 |